IL126268A0 - Purification of plasmid dna of pharmaceutical quality - Google Patents

Purification of plasmid dna of pharmaceutical quality

Info

Publication number
IL126268A0
IL126268A0 IL12626897A IL12626897A IL126268A0 IL 126268 A0 IL126268 A0 IL 126268A0 IL 12626897 A IL12626897 A IL 12626897A IL 12626897 A IL12626897 A IL 12626897A IL 126268 A0 IL126268 A0 IL 126268A0
Authority
IL
Israel
Prior art keywords
purification
plasmid dna
pharmaceutical quality
pharmaceutical
quality
Prior art date
Application number
IL12626897A
Other languages
English (en)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL126268A0 publication Critical patent/IL126268A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL12626897A 1996-03-21 1997-03-17 Purification of plasmid dna of pharmaceutical quality IL126268A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9603519A FR2746412B1 (fr) 1996-03-21 1996-03-21 Purification d'adn plasmidique de qualite pharmaceutique
PCT/FR1997/000472 WO1997035002A1 (fr) 1996-03-21 1997-03-17 Purification d'adn plasmidique de qualite pharmaceutique

Publications (1)

Publication Number Publication Date
IL126268A0 true IL126268A0 (en) 1999-05-09

Family

ID=9490391

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12626897A IL126268A0 (en) 1996-03-21 1997-03-17 Purification of plasmid dna of pharmaceutical quality

Country Status (15)

Country Link
US (1) US6730781B1 (xx)
EP (1) EP0902835A1 (xx)
JP (1) JP2000506736A (xx)
KR (1) KR100502116B1 (xx)
AU (1) AU730755B2 (xx)
BR (1) BR9708227A (xx)
CA (1) CA2249465A1 (xx)
CZ (1) CZ295587B6 (xx)
FR (1) FR2746412B1 (xx)
HU (1) HU225426B1 (xx)
IL (1) IL126268A0 (xx)
NO (1) NO984342L (xx)
SK (1) SK129198A3 (xx)
WO (1) WO1997035002A1 (xx)
ZA (1) ZA972462B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026468B2 (en) 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
US6214586B1 (en) * 1997-12-08 2001-04-10 Genzyme Corporation Method for purifying plasmid DNA and plasmid DNA substantially free of genomic DNA
NZ522860A (en) * 2000-05-26 2004-09-24 Gencell S Purification of a triple helix formation with an immobilized oligonucleotide
FR2822476B1 (fr) * 2001-03-23 2004-04-02 Aventis Pharma Sa Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice
HUP0303632A3 (en) * 2001-03-23 2005-12-28 Gencell Sa Methods for purifying and detecting double stranded dna target sequences by triple helix interaction
AU2003267175A1 (en) 2002-09-13 2004-04-30 Valentis, Inc. Apparatus and method for preparative scale purification of nucleic acids
EP2364769B1 (en) 2003-05-30 2016-01-13 VGXI, Inc. Devices and methods for biomaterial production
EP1664277B1 (en) * 2003-09-17 2011-11-09 Aventis Pharma S.A. Method of preparation of pharmaceutically grade plasmid dna
AU2005233309B2 (en) * 2004-04-19 2011-03-31 Centelion Method for purifying plasmid DNA
EP1737945B1 (en) * 2004-04-19 2011-01-26 Aventis Pharma S.A. Method for purifying plasmid dna
WO2006026125A2 (en) 2004-08-16 2006-03-09 Nature Technology Corp. Improved strains of e. coli for plasmid dna production
DK1817423T3 (en) 2004-11-30 2015-01-26 Merial Ltd Mixing units for chemical light ring of cells
US20120258502A1 (en) * 2011-04-08 2012-10-11 Vinod Pandiripally Method of producing recombinant plasmid dna using substantially solid growth medium
US20120283503A1 (en) * 2011-04-29 2012-11-08 The Johns Hopkins University Nanoparticle loaded stem cells and their use in mri guided hyperthermia
CN116790578B (zh) * 2023-08-22 2023-12-12 赛奥斯博生物科技(北京)有限公司 一种基于碱裂解法快速纯化质粒的生产工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2691586B2 (ja) * 1987-10-22 1997-12-17 旭光学工業株式会社 多孔質セラミックス及びその製法
JPH01135792A (ja) * 1987-11-20 1989-05-29 Mitsui Toatsu Chem Inc 核酸の分離・精製方法
CA2006008C (en) * 1988-12-20 2000-02-15 Donald J. Kessler Method for making synthetic oligonucleotides which bind specifically to target sites on duplex dna molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use
JPH08505534A (ja) * 1993-01-13 1996-06-18 森永乳業株式会社 Ｍ−ｃｓｆ２２３の製造方法
US5503816A (en) * 1993-09-27 1996-04-02 Becton Dickinson And Company Silicate compounds for DNA purification
US5747663A (en) * 1994-02-07 1998-05-05 Qiagen Gmbh Process for the depletion or removal of endotoxins
US5576196A (en) * 1995-01-13 1996-11-19 Vical Incorporated Process for reducing RNA concentration in a mixture of biological material using diatomaceous earth
KR100318808B1 (ko) 1996-02-06 2004-05-20 로셰 디아그노스틱스 게엠베하 정제핵산의제조방법및그의용도

Also Published As

Publication number Publication date
NO984342D0 (no) 1998-09-18
HU225426B1 (en) 2006-11-28
US6730781B1 (en) 2004-05-04
KR100502116B1 (ko) 2005-12-20
FR2746412B1 (fr) 1998-06-12
WO1997035002A1 (fr) 1997-09-25
AU730755B2 (en) 2001-03-15
AU2166197A (en) 1997-10-10
NO984342L (no) 1998-09-18
HUP9902152A2 (hu) 1999-11-29
BR9708227A (pt) 1999-07-27
HUP9902152A3 (en) 2001-04-28
SK129198A3 (en) 1999-03-12
KR20000064693A (ko) 2000-11-06
ZA972462B (en) 1997-09-29
CZ298498A3 (cs) 1999-01-13
JP2000506736A (ja) 2000-06-06
CA2249465A1 (fr) 1997-09-25
EP0902835A1 (fr) 1999-03-24
CZ295587B6 (cs) 2005-08-17
FR2746412A1 (fr) 1997-09-26

Similar Documents

Publication Publication Date Title
GB9626815D0 (en) Method of sequencing DNA
GB9620209D0 (en) Method of sequencing DNA
IL126268A0 (en) Purification of plasmid dna of pharmaceutical quality
GB9622500D0 (en) Therapeutic gene
AU3672797A (en) Affinity-based purification of oligonucleotides using soluble multimeric oligonucleotides
ZA979996B (en) Protein purification
HUP9903947A3 (en) Purification of neurotrophins
EP1027450A4 (en) METHOD FOR DNA SHUFFLING
GB9620769D0 (en) Nucleic acid sequencing
AU3796495A (en) Purification apparatus
GB9607066D0 (en) Purification process
AU4314099A (en) Novel method of large scale plasmid purification
EP1036159A4 (en) METHOD FOR PURIFYING PLASMID DNA AND PLASMID DNA THAT IS SUBSTANTIALLY FREE OF GENOMIC DNA
EP0517515A3 (en) Method of purifying dna
FR2753204B1 (fr) Procede de preparation d'adn plasmidique
AU3057399A (en) Glass microfiber column and method for the preparation and purification of plasmid dna using the same
HUP0003958A3 (en) Process for preparation of 4-aryl-piperidines and intermediates
AU4041997A (en) Dna purification procedure
GB2318350B (en) Process for purification of hydrochlorofluoroethanes
HUP9904173A3 (en) Pharmaceutical composition for treating viral diseases
PL335737A1 (en) Caprolactam purification process
GB9607440D0 (en) Analysis of DNA
AU5512598A (en) Matrix for rapid purification of nucleic acids
EP0801526A4 (en) GENE TRANSDUCTION SYSTEM
ZA981983B (en) Purification process